We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
(+4.3%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$190M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$171M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$139M |
| 4 |
Textron
TXT
|
+$133M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$325M |
| 2 |
EOG Resources
EOG
|
+$245M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Merck
MRK
|
+$149M |
| 5 |
Kohl's
KSS
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATAQ
776
DELISTED
Altimar Acquisition Corp III
ATAQ
| $6.83M | 0.01% |
+700,000
| New | +$6.89M |
|
|
FSRX
777
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $6.81M | 0.01% |
+700,000
| New | +$6.86M |
|
778
Unum
UNM
$14.4B
| $6.78M | 0.01% |
238,700
-5,300
| -2% | -$156K |
|
|
JOFF
779
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
| $6.76M | 0.01% |
+700,000
| New | +$6.83M |
|
|
HBI
780
DELISTED
Hanesbrands
HBI
| $6.76M | 0.01% |
361,941
-9,100
| -2% | -$180K |
|
781
Eledon Pharmaceuticals
ELDN
$272M
| $6.75M | 0.01% |
853,208
-39,347
| -4% | -$371K |
|
|
PACX
782
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $6.71M | 0.01% |
677,075
-322,925
| -32% | -$3.17M |
|
783
Freeport-McMoran
FCX
$96.9B
| $6.71M | 0.01% |
180,800
-1,601,300
| -90% | -$62.4M |
|
784
Five Star Bancorp
FSBC
$1.14B
| $6.62M | 0.01% |
+274,196
| New | +$7.11M |
|
785
DocGo
DCGO
$63.7M
| $6.61M | 0.01% |
664,462
-146,145
| -18% | -$1.45M |
|
|
CBAY
786
DELISTED
Cymabay Therapeutics
CBAY
| $6.32M | 0.01% |
1,450,000
| – | – |
|
787
CVRx
CVRX
$147M
| $6.3M | 0.01% |
+225,000
| New | +$6.3M |
|
788
Olema Pharmaceuticals
OLMA
$1.03B
| $6.3M | 0.01% |
+225,000
| New | +$6.4M |
|
|
RMGB
789
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
| $6.28M | 0.01% |
630,989
-134,115
| -18% | -$1.34M |
|
790
Treace Medical Concepts
TMCI
$309M
| $6.25M | 0.01% |
+200,000
| New | +$6.37M |
|
791
Voya Financial
VOYA
$9.11B
| $6.15M | 0.01% |
100,000
-350,000
| -78% | -$23M |
|
792
T. Rowe Price
TROW
$24.3B
| $6.14M | 0.01% |
+31,004
| New | +$5.8M |
|
793
Sutro Biopharma
STRO
$425M
| $6.04M | 0.01% |
32,500
-12,530
| -28% | -$2.45M |
|
794
Viant Technology
DSP
$253M
| $5.96M | 0.01% |
200,000
+150,729
| +306% | +$4.84M |
|
|
ABMD
795
DELISTED
Abiomed Inc
ABMD
| $5.94M | 0.01% |
19,043
-151,200
| -89% | -$46.4M |
|
796
Coursera
COUR
$1.72B
| $5.93M | 0.01% |
150,000
-150,000
| -50% | -$6.45M |
|
797
BuzzFeed
BZFD
$102M
| $5.92M | 0.01% |
150,000
| – | – |
|
|
PV
798
DELISTED
Primavera Capital Acquisition Corporation
PV
| $5.86M | 0.01% |
600,000
| – | – |
|
799
Fox Class B
FOX
$22B
| $5.84M | 0.01% |
165,865
-4,000
| -2% | -$145K |
|
|
VPCB
800
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
| $5.84M | 0.01% |
+600,000
| New | +$5.89M |
|
Similar funds
Adage Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
- Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
- Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
- Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
- Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
- Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
- Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.